Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to determine the safety, tolerability, and efficacy of 3 doses of Lecozotan (SRA-333) SR (2 mg, 5 mg and 10 mg) in patients with mild to moderate AD over 12 weeks.
Inclusion criteria
- Alzheimer's disease